Skip to content

EB Pharma Developments

Active Private limited companyfounded 2022active for 4 yearsAlkerstraat 28, 3570 AlkenKBO/BCE: BE 0780.755.671

Timeline

9 events since 2022

The 2026 accounts are due by 31-07-2027.

2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0780755671
Annual accounts 2025 filed PDFabbreviated format · 128 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 6 days before the deadline
2024
Back to profit net €3,567 The net result is €3,567, after one loss-making year.
Annual accounts 2023 filed PDFabbreviated format · 1 day before the deadline
2023
Weakest financial year net -€4,644 The net result drops to -€4,644, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2022 filed PDFmicro format · 22 days late
2022
IncorporationFounding capital of €1,500, 100 shares · Founded by (sole founder) · appointed as director · published on 25-01-20223 points ▸
  • Founded by (sole founder)
  • The founding capital is €1,500, divided into 100 shares
  • appointed as director
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

First establishment Alkerstraat 28, Alken

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 21 January 2022, EB Pharma Developments was incorporated as a private limited company by one private individual, with a starting capital of €1,500.12 has served as director since 2022.3 Total assets went from €22,037 in 2022 to €16,951 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 25-01-2022
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2022 and 2025

Next steps